Eicosapentaenoic Acid: all 56 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Lifestyle Interventions to Prevent cOgnitive Deficits in Subjects With Depressive Symptoms: From mEchanisms to Clinical pRacticeRecruitingNCT07462013Not applicable
- NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids StatusRecruitingNCT07439744Not applicable
- The Developmental Origins of ObesityRecruitingNCT06981676Not applicable
- Observing Metabolism of EPA With Consideration of Genetics And SexRecruitingNCT06975241Phase 4
- Impact of "Targeted" Nutritional Apport and Exercise on the Modulation of Metabolic and Immune-related Gene Expression Signatures in Early Breast Cancer (eBC) Patients Candidate to Neoadjuvant Therapy (NAT)RecruitingNCT06928701Not applicable
- Differential Thrombogenesis by EPA and DHA Mediated by HDLRecruitingNCT06494488Early Phase 1
- Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaTerminatedNCT04006847Phase 1/2Results posted
- Impact of Omega-3 Fatty Acid Oral Therapy on Healing of Chronic Venous Leg Ulcers in Older AdultsCompletedNCT03576989Not applicableResults posted
- Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and LipidsCompletedNCT02670382Not applicableResults posted
- Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized ApproachCompletedNCT02553915Phase 2/3Results posted
- Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB PatientsCompletedNCT01826422Not applicableResults posted
- Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer PreventionCompletedNCT01661764Phase 2Results posted
- Effect of EPA and HMB on Strength in ICU PatientsCompletedNCT01270516Not applicableResults posted
- Dose Response Effects of Marine Omega-3 Fatty Acids on InflammationCompletedNCT01078909Phase 3Results posted
- A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer CachexiaCompletedNCT00815685Not applicableResults posted
- Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPACompletedNCT00510692Phase 2/3Results posted
- Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major DepressionCompletedNCT00361374Phase 3Results posted
- Age-Related Eye Disease Study 2 (AREDS2)CompletedNCT00345176Phase 3Results posted
- Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationCompletedNCT00167310Phase 2Results posted
- The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric SymptomsCompletedNCT07711444Not applicable
- Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower OilsActive, not recruitingNCT07289919Not applicable
- Cardiometabolic Properties of Omega-3 Functionalized With HydroxytyrosolActive, not recruitingNCT06992323Not applicable
- The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild DementiaCompletedNCT04972643Not applicable
- EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)Status unknownNCT04335032Phase 3
- Long-term Safety and Efficacy Study of MND-2119 in Patients With HypertriglyceridemiaCompletedNCT04221217Phase 3
- Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking StatinsCompletedNCT03961763Not applicable
- Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate ThresholdTerminatedNCT03915535Phase 4
- Effect of EPA-FFA on Polypectomy in Familial Adenomatous PolyposisActive, not recruitingNCT03806426Phase 3
- Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish SoftgelsStatus unknownNCT03781557Phase 4
- Efficacy of MND-2119 in Participants With HypertriglyceridemiaCompletedNCT03693131Phase 3
- Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]Status unknownNCT03657758Phase 4
- Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular DystrophiesCompletedNCT03317171Not applicable
- EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes MellitusCompletedNCT03258840Not applicable
- Effects of WB-EMS and Specific Dietary Supplements on Cancer PatientsStatus unknownNCT03151291Not applicable
- Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDDTerminatedNCT03101540Early Phase 1
- Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During PregnancyTerminatedNCT03101527Early Phase 1
- Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to BehaviourCompletedNCT02615405Not applicable
- Effects of EPA on Prostate Cancer Cells Proliferation and Quality of LifeActive, not recruitingNCT02333435Phase 2
- Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel DiseasesCompletedNCT02179372Not applicable
- Effects of Eicosapentaenoic Acid on Subjects at High Risk for Colorectal CancerCompletedNCT02069561Not applicable
- The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic DermatitisWithdrawnNCT01936194Not applicable
- Metabolic Actions of Omega-3 Fatty AcidsCompletedNCT01896414Not applicable
- The Impact of Fish-oil Fatty Acids on Postprandial Vascular ReactivityCompletedNCT01692431Not applicable
- The Effects of EPA/DHA Supplementation on Cognitive Control in Children With ADHDCompletedNCT01554462Not applicable
- Effect of EPA on Aerobic Performance, Muscle, and Quality of Life in Colorectal Cancer Surgery PatientsStatus unknownNCT01320319Phase 2/3
- Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver MetastasesCompletedNCT01070355Phase 2
- Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI TumorStatus unknownNCT01048463Phase 3
- Effects of EPA and Vitamin E on Leptin, Adiponectin and Enzymatic Antioxidants in Type 2 DMCompletedNCT00817622Phase 4
- N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart FailureStatus unknownNCT00692718Phase 4
- Effects of Docosahexaenoic and Eicosapentaenoic Acids in Hypercholesterolemic Children Plus Diet on Docosahexaenoic Acid (DHA) StatusCompletedNCT00678067Not applicable
- Effects of Omega-3 Fatty Acids on Bone and FrailtyStatus unknownNCT00634686Phase 4
- Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein LevelsTerminatedNCT00578578Phase 4
- The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill PatientsCompletedNCT00487097Not applicable
- Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon MucosaCompletedNCT00432913Phase 2/3
- Ethyl-Eicosapentaenoic Acid and Tardive DyskinesiaCompletedNCT00114595Phase 4
- Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of AppetiteCompletedNCT00031707Phase 3